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Abstract
Central players of the adaptive immune system are the groups of proteins encoded in the
major histocompatibility complex (MHC), which shape the immune response against patho-
gens and tolerance to self-peptides. The corresponding genomic region is of particular inter-
est, as it harbors more disease associations than any other region in the human genome,
including associations with infectious diseases, autoimmune disorders, cancers, and neuro-
psychiatric diseases. Certain MHC molecules can bind to a much wider range of epitopes
than others, but the functional implication of such an elevated epitope-binding repertoire has
remained largely unclear. It has been suggested that by recognizing more peptide seg-
ments, such promiscuous MHC molecules promote immune response against a broader
range of pathogens. If so, the geographical distribution of MHC promiscuity level should be
shaped by pathogen diversity. Three lines of evidence support the hypothesis. First, we
found that in pathogen-rich geographical regions, humans are more likely to carry highly pro-
miscuous MHC class II DRB1 alleles. Second, the switch between specialist and generalist
antigen presentation has occurred repeatedly and in a rapid manner during human evolu-
tion. Third, molecular positions that define promiscuity level of MHC class II molecules are
especially diverse and are under positive selection in human populations. Taken together,
our work indicates that pathogen load maintains generalist adaptive immune recognition,
with implications for medical genetics and epidemiology.
Author summary
Variation in the human genome influences our susceptibility to infectious diseases, but
the causal link between disease and underlying mutation often remains enigmatic. Major
histocompatibility complex II (MHC class II) molecules shape both our immune response
against pathogens and our tolerance of self-peptides. The genomic region that encodes
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MHC molecules is of particular interest, as it is home to more genetic disease associations
than any other region in the human genome, including associations with infectious dis-
eases, autoimmune disorders, cancers, and neuropsychiatric diseases. Here, we propose
that MHC class II molecules can be categorized into two major types; specialists initiate
effective immune response against only relatively few pathogens, while generalists provide
protection against a broad range of pathogens. As support, we demonstrate that generalist
MHC class II variants are more prevalent in human populations residing in pathogen-
rich areas.
Introduction
The major histocompatibility complex (MHC) genes in vertebrates encode cell surface pro-
teins and are essential components of adaptive immune recognition [1]. MHC proteins are
endowed with highly variable peptide-binding domains that bind short protein fragments. The
MHC region is one of the most polymorphic gene clusters in vertebrate genomes [2]. Co-evo-
lutionary arms race with pathogens is considered largely responsible for the observed excep-
tionally high levels of genetic diversity [3–6], yet it cannot fully account for the observed
geographic differences in human MHC genetic diversity [7, 8]. This indicates that, beyond
MHC allelic diversity, other MHC-related factors contribute to the capacity of human popula-
tions to withstand pathogens. In this paper, we argue that peptide-binding repertoire size (or,
shortly, promiscuity) of MHC alleles is one important factor.
Recent empirical studies demonstrated that there is a substantial variation in the size of the
bound and presented antigen repertoire across MHC class I alleles. Certain MHC class I alleles
appear to be promiscuous and are capable of binding an exceptionally large set of epitope pep-
tide segments [9, 10]. For example, Paul and colleagues carried out bioinformatics analysis to
predict the binding capacity of common HLA-A and HLA-B alleles to a set of 30,000 dengue
virus–derived peptides [11]. The analysis revealed over 16-fold variation in the number of pep-
tides bound by the different alleles, indicating significant variation in epitope repertoire size
across HLA molecules. The authors selected three alleles for further study in an in vivo trans-
genic mouse model. Immunization of the corresponding HLA transgenic mouse strains with a
set of dengue virus–derived peptides revealed a positive relationship between epitope reper-
toire size and immunogenicity. Similarly, Kosmrlj and colleagues computed the fraction of
self-peptides that bind to various HLA-B molecules, and found that this fraction varies exten-
sively across four HLA-B alleles [12]. The authors then demonstrated that the self-peptide–
binding repertoire of HLA-B shapes the native repertoire of T-cell clones developed in the thy-
mus, with implications for recognizing human immunodeficiency virus (HIV) epitopes. Their
results could explain why individuals carrying HLA-B�57 alleles can maintain low HIV RNA
without therapy. Remarkably, analogous MHC class I alleles with the HLA-B�27 superfamily is
widespread in Chinese rhesus macaques, animals which show especially slow progression of
simian immunodeficiency virus (SIV)/HIV [13]. Finally, by focusing on seven chicken MHC
class I haplotypes and four human HLA-B alleles, Chappel and colleagues demonstrated that
MHC class I molecules that can bind a wide range of viral epitopes show lowered expression
on the cellular surfaces of immune cells, such as monocytes and lymphocytes [9]. The authors
suggested that the breadth of epitope-binding repertoire shapes genetic susceptibility to Mar-
ek’s disease virus in chickens and HIV disease progression in humans.
More generally, by recognizing more peptide segments, promiscuous MHC molecules may
promote immune response against a broader range of pathogens and are hence generalists [9,
10]. Prior case studies in chicken indicate that this may be so [14–17]. However, it remains to
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be established whether this relationship generally holds across MHC class I and II alleles and a
wide range of infectious diseases. Specifically, we propose that in regions of high pathogen
diversity, human populations should carry promiscuous MHC alleles. Moreover, as migrating
human populations have been exposed to changing sets of pathogens [18], shifts in MHC pro-
miscuity level should have occurred repeatedly and in a rapid manner during the course of
human evolution.
To test these predictions, we first focused on the human HLA class II DRB1 gene, for sev-
eral reasons. First, DRB1 is the most variable HLA class II locus, with over 2,000 registered
alleles [19]. Together with HLA-DRA, HLA-DRB1 encodes the heterodimeric HLA-DR pro-
tein complex, but HLA-DRA is basically invariant. Second, DRB1 shows the strongest general
signature of selection among HLA class II loci [20], while at the same time showing the weak-
est evidence for divergent allele advantage, an alternative mechanism at the genotype level for
presenting a broader set epitopes [21]. Third, DRB1 has diversified very rapidly in the human
lineage [22]. Many of the DRB1 alleles appear to be human specific and most likely evolved
after the migration of ancestral human populations out of Africa [22]. These periods have been
associated with human populations encountering numerous new pathogens [18, 23]. For other
HLA class II loci, the level of genetic diversity is lower [19, 24], probably driven by selection
for functions partly unrelated to pathogens. Notably, HLA-DQ has a fundamental role in the
development of immune tolerance [25, 26], while HLA-DP contributes to the presentation of
epitopes of intracellular origins [27–29]. Fourth, epitope-binding prediction algorithms show
higher accuracy for DRB1 than for other HLA class II loci [30, 31]. Finally, the abundance of
DRB1 on the cell surface is especially high compared with other HLA class II molecules [32–
34]. Subsequently, we also evaluated promiscuity patterns of HLA class I molecules.
Estimates on epitope-binding promiscuity were derived from two sources: experimental
assays that measured individual peptide–MHC interactions in vitro and systematic computa-
tional predictions. In a series of analyses, we show that predictions of our hypothesis are
upheld, regardless of how HLA-DRB1 promiscuity level is estimated.
Results
Estimating HLA-DRB1 promiscuity level
Given that large-scale experimental assays to measure individual peptide–MHC interactions
are extremely tedious, we first employed established bioinformatics tools to predict the bind-
ing affinities of experimentally verified epitope peptides for a panel of 162 nonsynonymous
HLA-DRB1 alleles, all of which are present at detectable frequencies in at least one human
population [35–37]. The set of investigated epitopes was derived from the Immune Epitope
Database (IEDB) and contains 2,691 peptide epitopes of 71 pathogens known to be bound by
certain HLA class II alleles [38] (S1 Data). Epitopes showing high levels of amino acid similar-
ity to each other were excluded from the analysis (See Methods). Most included epitopes are
15 to 20 amino acids long and are found in only one of the 71 pathogens (S1 Fig, S1 Data). The
NetMHCIIpan algorithm was used to predict individual epitope–MHC interactions [30], not
least because it outperforms other prediction algorithms [31]. The breadth of epitope-binding
repertoire or, shortly, the level of promiscuity of individual HLA-DRB1 alleles was estimated
as the fraction of epitopes with a binding affinity stronger than 50 nM to the given MHC mole-
cule. This threshold corresponds to high-affinity binding, which is frequently observed in
MHC molecules displaying immunodominance [39]. We found large variation in promiscuity
levels across HLA-DRB1 alleles (S2 Fig, S2 Data). Using a smaller dataset with information
from both approaches, we show that the computationally predicted and the empirically esti-
mated promiscuity values are strongly correlated with each other (Spearman’s rho: 0.78,
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P = 0.004, S3 Fig). Moreover, our results are robust to changes in the affinity threshold (S4A to
S4C Fig), usage of other prediction algorithms (S4D Fig), and variation in the epitope data
employed (S4E Fig). As expected, promiscuous HLA-DRB1 alleles can present epitopes from a
broader range of pathogen species (S5 Fig). Reassuringly, there was no correlation between
allele promiscuity values and the amount of data per allele used for the training of the algo-
rithm (Spearman’s rho: −0.38, P = 0.21).
Global distribution of promiscuous HLA-DRB1 alleles
Taking advantage of the confirmed reliability of computational predictions, we next investi-
gated the geographic distribution of HLA-DRB1 alleles. We first collected high-quality
HLA-DRB1 allele prevalence data of 96 human populations residing in 43 countries from two
databases and an article [35–37]. The weighted average of promiscuity level in each population
was calculated based on the promiscuity values and allele frequencies of individual alleles in
the population (See Methods). The analysis revealed a large variation in mean promiscuity
across geographical regions and the corresponding human populations (S1 Table). Impor-
tantly, several distantly related but highly promiscuous alleles contribute to this pattern (S1
Table). Notably, an especially high allelic promiscuity level was found in Southeast Asia, an
important hot spot of emerging infectious diseases [40]. To minimize any potential confound-
ing effect of high genetic relatedness between neighboring populations, we merged popula-
tions with similar HLA allele compositions for all further analyses (See Methods).
Link between pathogen diversity and HLA-DRB1 promiscuity level
Using the Global Infectious Diseases and Epidemiology Network (GIDEON), we compiled a
dataset on pathogen richness in the corresponding 43 geographic regions [41]. It consists of 95
diseases caused by 168 extracellular pathogens, including diverse bacterial species, fungi, pro-
tozoa, and helminthes. Using the same protocol, we additionally compiled a dataset on the
prevalence of 149 diseases in the same regions caused by 214 viral and other obligate intracel-
lular pathogens. The dataset and methodology employed for the analysis are standardized and
have been used previously in similar contexts [7, 8, 42].
We report a strong positive correlation between extracellular pathogen diversity and mean
promiscuity: HLA-DRB1 alleles that can bind epitopes from a broader range of pathogens are
more likely to be found in regions of elevated pathogen diversity (Fig 1A). This pattern is
unlikely to be explained by confounding factors, such as country size or HLA-DRB1 genetic
diversity across countries (S2 Table). By contrast, we found no significant association between
HLA-DRB1 promiscuity level and diversity of intracellular pathogens (Fig 1B). We conclude
that the geographical distribution of promiscuous HLA-DRB1 alleles has been mainly shaped
by the diversity of extracellular pathogens.
The above results hold—and are even stronger—when estimates on promiscuity were
derived from empirical in vitro MHC binding data (shortly, in vitro promiscuity), downloaded
from the IEDB database [38] (Fig 1C and 1D, S2 Table and S3 Data). However, these results do
not exclude the possibility that the geographical link between pathogen diversity and promis-
cuity is indirect. More direct support on the causal relationship between the two variables
comes from analysis of prior human genetic studies. To investigate this issue, we focused on
two geographically widespread allelic groups with exceptionally high (HLA-DRB1�12) and
exceptionally low (HLA-DRB1�03) promiscuity values, respectively, and conducted literature
mining on their reported associations with infectious diseases (S3 Table). As expected,
HLA-DRB1�12 was associated with protection against at least five infectious diseases, while
HLA-DRB1�03 was associated with susceptibilities to eight infectious diseases, which is highly
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unlikely by chance (Fisher test, P = 0.003) (S3 Table, S5 Data). The data also indicate local
adaptation towards elevated promiscuity under diverse pathogen pressure. The HLA-
DRB1�12:02 allele is prevalent in specific regions of Southeast Asia. Compared with other
alleles detected in this region, HLA-DRB1�12:02 has a relatively high promiscuity value (top
Fig 1. Relationship between epitope-binding promiscuity and pathogen diversity. Normalized population-level promiscuity of HLA-DRB1
alleles is shown as the function of extracellular pathogen diversity, as approximated by species count. Promiscuity scores were calculated based on
standardized (i.e., z-score) allele promiscuity values and were averaged in each population group (see Methods). Significant correlations were
found between extracellular pathogen species count and (A) predicted allele promiscuity level in 37 groups (Spearman’s rho: 0.5, P = 0.002) and
(C) in vitro promiscuity level in 28 groups (Spearman’s rho: 0.7, P = 3�10−5). No significant correlation was found between intracellular pathogen
diversity and (B) predicted and (D) in vitro promiscuity at the HLA-DRB1 locus (Spearman’s rho: 0.04 and 0.21, P = 0.81 and 0.29, respectively).
Dashed lines indicate smooth curve fitted using cubic smoothing spline method in R (see Methods). Population groups were created using the
15th percentile genetic distance cutoff (see Methods). For results obtained upon using alternative distance cutoff values, see S3 Data. The
underlying data for this figure can be found in S4 Data.
https://doi.org/10.1371/journal.pbio.3000131.g001
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20%, Fig 2A, S2 Data). The high frequency of HLA-DRB1�12:02 has been previously suggested
to reflect pathogen-driven selection during the migration of a Mongolian population to South
China [43]. Indeed, this allele is associated with protection from recurrent pulmonary tubercu-
losis, recurrent typhoid fever, and hepatosplenic schistomiasis (S5 Data), all of which are
endemic diseases in Southeast Asia [44–46]. Remarkably, the frequency of this allele increases
with extracellular pathogen diversity in this region (Fig 2B). Together, these observations sup-
port the hypothesis that promiscuous epitope binding of HLA-DRB1 alleles is favored by selec-
tion when extracellular pathogen diversity is high.
Evolution of promiscuous HLA alleles
An important unresolved issue is how promiscuity has changed during the course of human
evolution. Under the assumption that local pathogen diversity drives the evolution of epitope
recognition of HLA class II alleles, promiscuity as a molecular trait should have evolved rapidly
as human populations expanded into new territories. To investigate this issue, we combined
an established phylogeny of HLA-DRB1 alleles [47] with predicted epitope-binding promiscu-
ity values. We found that alleles with a high promiscuity level have a patchy distribution across
the tree (S6 Fig), indicating that high promiscuity has multiple independent origins. To inves-
tigate this observation further, we selected a set of 96 HLA-DRB1 alleles with a detectable fre-
quency in at least one human population and appropriate sequence data (see Methods). A
comparison of all pairs of these alleles revealed that even very closely related alleles show major
differences in promiscuity levels (Fig 3A). For example, alleles belonging to the HLA-DRB1�13
group show over 98% amino acid sequence identity to each other, but display as much as
57-fold variation in the predicted promiscuity levels. We conclude that the switch between
high and low promiscuity levels has occurred repeatedly and in a rapid manner during the alle-
lic diversification of the HLA-DRB1 locus.
Fig 2. HLA-DRB1�12:02 allele promiscuity level and extracellular pathogen diversity in Southeast Asia. (A) HLA-DRB1�12:02 has an
exceptionally high promiscuity level compared with other alleles. The figure shows alleles with at least 10% frequency in at least one
population in Southeast Asia. Predicted allele promiscuity values are shown. (B) The mean frequency of DRB1�12:02 increases with
extracellular pathogen diversity across population groups (Spearman’s rho: 0.57, P = 0.017). Populations that resided in China, Japan,
South Korea, Indonesia, Malaysia, and the Philippines were included in the analysis. Red curve indicates smooth curve fitted using cubic
smoothing spline method in R (see Methods). The underlying data for this figure can be found in S4 Data.
https://doi.org/10.1371/journal.pbio.3000131.g002
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We next asked how selection on promiscuity has shaped the genetic diversity along the epi-
tope-binding region of HLA molecules. To quantify protein sequence variability at each amino
acid position, we calculated the Shannon entropy index based on the alignment of the 96
selected HLA-DRB1 alleles from above. For each position, we also calculated promiscuity fra-
gility, that is, the median impact of single amino acid substitutions on promiscuity (see Meth-
ods). A strong positive correlation was found between Shannon entropy and promiscuity
fragility (Fig 3B, Spearman’s rho = 0.76, P = 0.0001). Importantly, this conclusion does not
depend on how sequence polymorphism was estimated (S7 Fig). Accordingly, amino acid
positions with a large impact on epitope-binding promiscuity are highly variable in human
populations. Furthermore, those sites in the epitope-binding region that are under positive
selection [48] tend to have high promiscuity fragility values (Wilcoxon rank sum test,
P = 0.0012, Fig 3B; see also S8 Fig). The above data suggest a link between allele promiscuity
and HLA-DRB1 diversification, probably as an outcome of selection for locally optimized pro-
miscuity levels.
Finally, we note that several variable molecular sites in the binding region of HLA-DRB1
affect epitope-binding characteristics without any major impact on promiscuity per se. For
example, our computational analysis indicates that mutations at amino acid site numbers 9
and 47 do not seriously affect promiscuity level (Fig 3B). However, several mutations at these
sites are associated with binding self-peptides and thereby shape vulnerability to specific auto-
immune diseases [49, 50].
Fig 3. Promiscuity changes rapidly during evolution and might be a selectable trait. (A) For all pairs of selected alleles, the predicted promiscuity difference between
two HLA-DRB1 alleles is shown as a function of amino acid distance measured after excluding the epitope-binding region. Large differences in promiscuity can be
observed even between closely related pairs of alleles (e.g., at zero amino acid distance). As a result, there is no correlation between amino acid distance and promiscuity
fold difference (Spearman’s rho = 0.02, P = 0.19). Amino acid distances were binned as shown on the figure (n = 308, 1,168, 564, 654, 1,492). Violin plots show the
density function of promiscuity fold difference values for allele pairs in the given bin. White circles show median values; bold black lines show the interquartile range.
(B) Sequence variability of an amino acid site in the epitope-binding region of HLA-DRB1 (measured as Shannon entropy) correlates positively with the site’s
promiscuity fragility, measured as the median predicted promiscuity fold difference caused by a random amino acid change at the given site (see inset, Spearman’s rho:
0.76, P = 0.0001). Sites that have a larger impact on promiscuity are more diverse in human populations. Line in inset represents linear regression between the two
variables. The same result was obtained when promiscuity fragility was calculated based on nucleotide substitutions instead of amino acid substitutions (Spearman’s rho:
0.73, P = 0.0004, see Methods) or when sequence variability was measured as nonsynonymous nucleotide diversity (πA) instead of sequence entropy (S7 Fig). Sites under
positive selection as identified by Furlong and colleagues [48] show significantly higher promiscuity fragility (Wilcoxon rank sum test, P = 0.0012) and are marked with
asterisks (see also S8 Fig). The underlying data for this figure can be found in S4 Data.
https://doi.org/10.1371/journal.pbio.3000131.g003
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Pathogen diversity and HLA class I promiscuity
The relationship between pathogen diversity and epitope-binding promiscuity may be more
general, as similar results hold for the HLA-A locus. HLA-A is one of the three types of classi-
cal human MHC class I molecules and is mainly involved in the presentation of epitopes from
intracellular pathogens [51]. In agreement with expectation, we report a positive correlation
between local intracellular pathogen diversity and the HLA-A promiscuity level of the corre-
sponding human populations (S9A and S9B Fig, S3 Data). No marked positive correlation was
found for two other MHC class I genes (HLA-B and HLA-C, see S9C to S9F Fig, and S3 Data).
Therefore, other unrelated evolutionary forces may shape the geographical distribution of pro-
miscuous HLA-B and HLA-C alleles (S1 Text).
Discussion
Central players of the adaptive immune system are the groups of proteins encoded in the
MHC. By binding short peptide segments (epitopes), MHC molecules guide both immune
response against pathogens and tolerance to self-peptides. The genomic region encoding these
MHC molecules is of special interest, for two reasons. It harbors more disease associations
than any other regions in the human genome, including associations with infectious diseases,
autoimmune disorders, tumors, and neuropsychiatric diseases [52, 53]. A growing body of lit-
erature is now revealing that certain MHC class I alleles can bind a wider range of epitopes
than others, but the functional implications of this variation remain largely unknown [10]. By
recognizing a larger variety of epitopes, such promiscuous MHC alleles promote immune
response against a broader range of pathogens at the individual level. Therefore, promiscuous
epitope binding of MHC molecules should be favored by selection in geographic regions
where extracellular pathogen diversity is high. Importantly, this mechanism is conceptually
distinct from the well-established concept of heterozygote advantage at the MHC [54], as it
concerns individual alleles and not allele combinations or genotypes.
To test this hypothesis, we combined data on the geographic distribution of human MHC
class II alleles and prevalence of extracellular pathogens, empirical/computational estimates of
epitope-binding promiscuity, and phylogenetic analyses. Our main findings, strongly support-
ing our hypothesis, are as follows.
First, in geographical regions of high extracellular pathogen diversity, human HLA-DRB1
alleles have exceptionally high epitope-binding repertoires. This suggests that the geographical
distribution of promiscuous HLA-DRB1 alleles has been shaped by the diversity of extracellu-
lar pathogens. The HLA-DRB1�12:02 allele highlights this point. HLA-DRB1�12:02 is a pro-
miscuous allele that has been associated with protection from certain infectious diseases (S5
Data). As expected, this allele is especially prevalent in regions of Southeast Asia with elevated
pathogen load (Fig 2B).
It is well established that antigens presented by HLA class II molecules derive mainly from
extracellular proteins [1]. However, HLA class II molecules have well-established roles in con-
trolling immune response against viruses [55, 56]. Additionally, viral peptides are reported to
be processed and presented also by the HLA class II pathway [57]. Therefore, it remains to be
established why intracellular pathogen diversity has no major impact on the global distribution
of HLA-DRB1 alleles.
Notably, the relationship between pathogen load and epitope-binding promiscuity may be
more general, as similar results hold for the HLA-A locus: we found a positive correlation
between local intracellular pathogen diversity and the HLA-A promiscuity level of the corre-
sponding human populations (S9A and S9B Fig, S3 Data).
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Second, a phylogenetic analysis revealed major differences in promiscuity levels of very
closely related HLA-DRB1 alleles. This suggests that high promiscuity level in HLA-DRB1 has
evolved rapidly and repeatedly during human evolution. Finally, amino acid positions with a
prominent role in shaping HLA-DRB1 promiscuity level are especially variable in human pop-
ulations and tend to be under positive selection. In sum, we conclude that HLA promiscuity
level is a human trait with paramount importance during adaptation to local pathogens.
Our work has important ramifications for future studies. MHC is the most variable region
of the human genome, and the variation is associated with numerous infectious and immune-
mediated diseases [52, 53, 58–62]. The impact of MHC promiscuity level on population allelic
diversity is an interesting area for future research. In a similar vein, MHC allelic diversity is
associated with olfaction-based mating preferences in human and other animals [63]. The
roles of MHC promiscuity in mating success and mating preferences are a terra incognita.
We note that the most promiscuous HLA-DRB1 alleles are rare in certain human popula-
tions (S1 Table; S2 Data). This suggest that these alleles are not particularly favored by natural
selection in these areas. Why should it be so? First, high promiscuity may not be able to cope
with the rise of novel and highly virulent pathogens. In such cases, displaying a particular epi-
tope might be the most efficient way to achieve resistance, and high promiscuity might be sub-
optimal due to a reduced specificity [9, 10]. Second, high promiscuity level may elevate the risk
of immune reactions against host tissues and non-harmful proteins [9, 64]. Clearly, future
work should elucidate the evolutionary trade-offs between protection from pathogens and
genetic susceptibility to autoimmune diseases. This will require high-throughput experimental
methods to determine epitope-binding repertoire [65], and HLA transgenic mice studies on
the role of promiscuity in immune response [66].
Finally, genetic variation within particular MHC genes influences vaccine efficacy [67],
rejection rates of transplanted organs [68], susceptibility to autoimmune diseases [49], and
antitumor immunity [28, 69, 70]. Our work raises the possibility that, by altering the matura-
tion and functionality of the immune system, the size of the epitope-binding repertoire of
MHC alleles itself could have an impact on these processes. The exact role of MHC promiscu-
ity in these crucial public health issues is an exciting future research area.
Methods
Computational prediction of epitope-binding promiscuity
The IEDB has collected the results of individual and systematic studies on epitope binding by
MHC alleles [38]. The experimental studies include HLA-binding assays, T-cell activation
assays, and immunopeptidomic studies as well. Epitopes of all available viral, bacterial, and
eukaryotic pathogens known to be bound by at least one HLA-I or HLA-II allele were
extracted from IEDB. Reference proteomes of pathogenic species that carry at least one of the
collected epitope sequences were retrieved from the Uniprot database (102 for HLA-I and 71
for HLA-II epitopes) [71]. Only epitopes of these species were analyzed further. All proteomes
were scanned for each epitope sequence, and epitope sequences found in only one proteome
(i.e., species-specific epitopes) were kept for further analysis. Highly similar epitope sequences
were identified using Clustal Omega [72] and excluded as follows. A protein distance matrix
was created and epitopes were discarded iteratively. In each iteration, the epitope pairs with
the lowest k-tuple distance were identified. Then, the epitope with the highest average similar-
ity to all other sequences was excluded. Iterations were repeated until distance values less than
0.5 (corresponding to greater than approximately 50% sequence identity) were eliminated
from the matrix [73]. Note that this filtering procedure was carried out separately for epitope
sequences bound by HLA-I and HLA-II.
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Binding affinities of the remaining 3,265 HLA-I epitope sequences to 346 HLA-A, 532
HLA-B and 225 HLA-C alleles were predicted with the NetMHCpan-4.0 algorithm [74]. The
binding of 2,691 HLA-II epitope sequences to 162 HLA-DRB1 alleles was predicted using the
NetMHCIIpan-3.1 algorithm [30]. All 162 alleles are present in at least one of the human pop-
ulations studied here (see below). The “pep” sequence input format was used for both HLA-I
and HLA-II epitope-binding prediction. A binding affinity threshold of 50 nM was applied,
yielding peptides that are likely to be immunodominant [39]. For alternative binding threshold
definitions, see S4 Fig. For each binding threshold, epitope-binding promiscuity was defined
as the fraction of the epitope set bound by a given allele.
Calculating epitope-binding promiscuity using in vitro data
To determine the epitope-binding promiscuity of HLA-DRB1 alleles based on previously pub-
lished experimental data, we used the IEDB database [38]. Specifically, we downloaded all
MHC ligand and T-cell assay data, which was available for 48 HLA-DRB1 alleles. Binding data
of 20 alleles screened for at least 100 ligands each were further analyzed. The epitope set of
each allele was filtered for highly similar sequences, as described above. As the majority of in
vitro assay data were available in a binary format (i.e., presence or absence of binding), promis-
cuity was calculated as the fraction of positive binding assays for a given allele.
Calculating promiscuity levels of human populations
To calculate population-level promiscuity values, we obtained HLA allele frequency data from
the Allele Frequency Net Database (AFND) and the International Histocompatibility Working
Group (IHWG) populations [35, 36]. Haplotype-level data of the 13th International HLA and
Immunogenetics Workshop (IHIW) populations were downloaded from dbMHC (National
Center for Biotechnology Information [NCBI]; ftp://ftp.ncbi.nlm.nih.gov/pub/mhc/mhc/Final
%20Archive). Additionally, allele frequency data of the 14th and 16th IHIW populations, as
published by Riccio and colleagues [37], and populations in the AFND were used in the analy-
ses. To avoid potential confounding effects of recent genetic admixture and migration, we
focused on native populations, similarly to previous studies (S1 Table) [7, 8]. We excluded
IHWG populations reported to deviate from Hardy-Weinberg equilibrium [37]. Among the
AFND populations and IHWG populations without haplotype-resolution data (14th and 16th
IHIW), those comprising less than 100 genotyped individuals or those in which the sum of
allele frequencies deviated from 1 by more than 1% were excluded. Populations reported in
multiple databases were included only once in the analysis.
For each HLA loci, we calculated mean population promiscuity by averaging promiscuity
values of alleles weighted by their relative frequencies in the populations. In all of these calcula-
tions, we used standardized (i.e., z-score) promiscuity values to make the in silico and in vitro
values more easily comparable. Finally, when calculating population-level promiscuity based
on in vitro promiscuity data, we excluded populations for which in vitro promiscuity values
could be assigned to less than 50% cumulative allele frequency.
To tackle the issue of nonindependence of data points, we focused on populations instead
of countries and grouped those populations that have highly similar HLA allele compositions,
based on standard measures of genetic distance (see below). We merged populations with
highly similar HLA allele compositions, allowing us to avoid pseudoreplication of data points
while retaining informative allele frequency differences between populations residing in the
same broad geographical areas.
To this end, we first generated a genetic distance matrix between populations with the ade-
genet R library using allele frequency data of the examined locus. We used the Rogers’ genetic
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distance measure [75] because it does not assume that allele frequency changes are driven by
genetic drift only, an unlikely scenario for HLA genes. Next, populations were merged using a
network-based approach. Populations were treated as nodes and two nodes were connected if
their genetic distance was under a cutoff value. Populations were grouped in an iterative man-
ner. In each iteration, all maximal cliques (i.e., subsets of nodes that are fully connected to each
other) in the network were identified. Maximal cliques represent groups of populations in
which all populations have similar allele compositions to each other. Then, mean genetic dis-
tance within each clique was calculated. The clique with the lowest average distance was
selected and its populations were grouped together. Then, this clique was deleted from the net-
work. Iterations were repeated until no maximal cliques remained in the network. Grouping
of populations was carried out using different distance value cutoffs (1st, 5th, 10th, and 15th
rank percentile of all distance values). The resulting population groups and the individual pop-
ulations that remained in the network were treated as independent data points in subsequent
statistical analyses. Mean promiscuity level in population groups was calculated by averaging
population promiscuity values.
Unless otherwise indicated, all figures are based on population groups using the 15th per-
centile genetic distance cutoff value. Importantly, using different cutoffs has no impact on our
results (S3 Data). Finally, we note that genetic differences among human populations mostly
come from gradations in allele frequencies rather than from the presence of distinctive alleles
[76]. Therefore, traditional clustering of populations based on HLA composition would have
been ill-suited for our purposes.
Pathogen diversity
Data on 309 infectious diseases were collected from GIDEON [41]. For each disease, the num-
ber of causative species or genera (when species were not listed for the genus) was determined
using disease information in the GIDEON database, as described previously [42]. Causative
agents were classified into obligate intracellular and extracellular pathogen groups based on a
previous study [7] and literature information. Putative facultative intracellular pathogens were
excluded from the analysis. Diseases caused by agents that could not be clearly classified were
also excluded from the analysis. Extracellular and intracellular pathogen diversity (richness) of
each country was approximated by the number of identified endemic extracellular and intra-
cellular species, respectively.
Finally, we assigned country-level measures of pathogen and HLA diversity to population
groups as follows. For each population group, extracellular and intracellular pathogen counts
were calculated by averaging the corresponding country-level values across the populations
within the group. For example, if a population group contained two populations residing in
neighboring countries, then we assigned the average pathogen diversity of the two countries to
it.
Literature mining of associations between HLA alleles and infectious
diseases
To examine associations between selected HLA allele groups and infectious diseases, we car-
ried out a systematic literature search on PubMed database using the following terms:
“assoc� drb1 12 02”, “assoc� drb1 1202”, “assoc� drb1 12 01”, “assoc� drb1 1201”, “assoc�
dr12”, “assoc� drb1�12”, “assoc� drb1 03 01”, “assoc� drb1 0301”, “assoc� dr3”, “assoc�
drb1�03”, “assoc� dr17”, “infect� drb1 12 02”, “infect� drb1 1202”, “infect� drb1 12 01”, “infect�
drb1 1201”, “infect� dr12”, “infect� drb1�12”, “infect� drb1 03 01”, “infect� drb1 0301”, “infect�
dr3”, “infect� drb1�03”, and “infect� dr17”.
Pathogen diversity drives the evolution of generalist MHC-II alleles in human populations
PLOS Biology | https://doi.org/10.1371/journal.pbio.3000131 January 31, 2019 11 / 21
“assoc�” and “infect�” refer to any word beginning with these letters.
Each resulting paper containing HLA association data was examined, and statistically sig-
nificant associations between allele groups (DRB1�03 or DRB1�12) or common alleles in allele
groups (DRB1�12:01, DRB1�12:02, DRB1�03:01) and infectious diseases were collected. Asso-
ciations with diseases caused by intracellular pathogens were excluded from the analysis.
HLA-disease associations were classified as beneficial or detrimental, if all related studies sup-
ported the beneficial or detrimental role of HLA allele/allele group in the development or
course of the given disease. Otherwise, the association was classified as controversial. The
results were summarized (S3 Table), and statistical association between beneficial/detrimental
effects and high/low promiscuity across allele groups was determined by a Fisher’s exact test.
Amino acid distance between DRB1 alleles
We used amino acid distance as a proxy for phylogenetic distance between pairs of DRB1
alleles. To this end, nucleotide sequences of DRB1 alleles that contained full exon 2 and 3
regions were downloaded from the IPD-IMGT/HLA database [19]. To limit our analyses to
alleles that have an impact on the inferred promiscuity level of a population, we considered
only those sequences that had a nonzero frequency in at least one human population (see
above). From allele groups that code for the same protein sequence (synonymous differences,
differentiated by the third set of digits in the HLA nomenclature), one of the alleles was ran-
domly chosen. This selection procedure resulted in 96 alleles. Multiple alignment of nucleotide
sequences was performed using the MUSCLE algorithm as implemented in the MEGA soft-
ware [77] and converted to protein sequence alignments. Amino acid distance was calculated
using the Jones-Taylor-Thornton substitution model in MEGA [77] (Fig 3A). Epitope-binding
region sites—as defined previously [30]—were excluded when calculating amino acid distance.
The rationale behind this exclusion is that these sites are known to be under positive selection
[78, 79] and are therefore less informative on evolutionary distance. Additionally, by removing
these sites, the amino acid distance remains independent of promiscuity predictions. Finally,
as intragenic recombination may distort the inference of evolutionary distance, we identified
such events across all alleles following the protocol of Satta and colleagues [80] using GENE-
CONV [81] and RDP algorithms [82] as implemented in the RDP software [83]. Recombinant
alleles were removed when calculating amino acid distance.
Sequence diversity and promiscuity fragility
We first defined the epitope-binding region of HLA-DRB1 alleles, as previously [30]. To esti-
mate sequence diversity along the epitope-binding region, we employed two measures: stan-
dard Shannon entropy [84] and nucleotide diversity (π), a widely employed measure of genetic
variation [85].
Using the protein sequence alignment of the 96 alleles defined above, we calculated amino




where Pi is the fraction of residues of amino acid type i at a given site, and M is the number of
amino acid types observed at that site.
Nonsynonymous nucleotide diversity (πA) measures the average number of nonsynon-
ymous nucleotide differences per nonsynonymous site between two randomly chosen protein
coding DNA sequences from the same population [85, 86]. πA was calculated for each amino
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acid site in the epitope-binding region for each population using DnaSP software [87] and cus-
tom-written R scripts. Nucleotide sequences of DRB1 alleles were downloaded from the
IPD-IMGT/HLA database [19].




xi � xj � pAij
where xi and xj are the frequencies of the ith and jth alleles in the population, respectively, and
pAij is the number of nonsynonymous nucleotide differences per nonsynonymous nucleotide
site between the two codon sequences of the given amino acid site in the ith and jth alleles. To
calculate πA for each population, allele frequency data of human populations were obtained, as
described earlier (see above). An overall nucleotide diversity index was calculated by averaging
πA across populations.
To calculate each amino acid site’s impact on epitope-binding promiscuity (promiscuity
fragility), promiscuity was predicted for each 19 possible amino acid change along the epitope-
binding region of each of 96 alleles. The fold difference in promiscuity resulting from each
amino acid substitution was calculated. The median promiscuity fold difference of each possi-
ble allele and amino acid change combination (96 × 19) was used to estimate promiscuity fra-
gility at each amino acid position. As some of the 19 possible amino acid changes are not
accessible via a single nucleotide mutation, and the accessible amino acid changes can have dif-
ferent likelihoods based on the codon sequence of the site and the genetic code, we also calcu-
lated promiscuity fragility based on each nonsynonymous nucleotide substitution of the codon
instead of each amino acid substitution of the site.
Statistical analysis and graphical representation
All statistical analyses were carried out in R version 3.2.0 [88]. Smooth curves were fitted using
the cubic smoothing spline method [89].
Supporting information
S1 Fig. Length distribution of 2,691 epitopes used for the prediction of HLA-DRB1 allele
promiscuity. The underlying data for this figure can be found in S4 Data.
(TIF)
S2 Fig. Epitope-binding promiscuity values show large variation across alleles. The plot
shows the fraction of epitopes bound by HLA-DRB1 alleles, as predicted computationally.
Each allele is present in at least 1% frequency in at least one examined human population. The
underlying data for this figure can be found in S4 Data.
(TIF)
S3 Fig. Correlation between computationally predicted and in vitro–measured allele pro-
miscuity levels. To verify the accuracy of computational promiscuity predictions, a quantita-
tive in vitro dataset containing 44,541 experimentally measured binding affinity values for 11
HLA-DRB1 alleles was downloaded from the IEDB database [38]. We selected (i) 216 epitope
sequences from this dataset, for which binding affinity data to all the 11 alleles were available,
and (ii) 2,665 epitopes used for calculating in silico promiscuity throughout the paper, which
were not used for the training of the NetMHCIIpan algorithm. In vitro and predicted promis-
cuity of the 11 alleles was determined at a 50 nM binding threshold using the selected 216 and
2,665 epitopes, respectively. We used standardized (i.e., z-score) allele promiscuity values for
the comparisons. We report a strong correlation between the in silico and in vitro promiscuity
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scores (Spearman’s rho: 0.78, P = 0.004). The red dashed line represents a linear regression
line. The underlying data for this figure can be found in S4 Data. IEDB, Immune Epitope Data-
base.
(TIF)
S4 Fig. Predicted promiscuity levels are robust to changes in binding threshold, prediction
algorithm, and epitope set. The computational prediction of epitope-binding promiscuity was
carried out using different binding thresholds: 50 nM for strong binding, which results in the
selection of immunodominant peptides [39], and 500 nM and 1,000 nM thresholds, which min-
imize the number of false negative hits [90]. (A-C) The proportion of 2,691 epitopes bound by
HLA-DRB1 alleles showed strong correlation between (A) 50 nM and 500 nM, (B) 50 nM and
1,000 nM, and (C) 500 nM and 1,000 nM binding thresholds (Spearman’s rho: 0.95, 0.91, and
0.99 respectively, P< 2 × 10−16 for all analyses). (D) To further ensure the robustness of the
predicted promiscuity values, we repeated the predictions using an alternative algorithm,
MHC2SKPan as implemented by the MHC2SKPan server [91] (again, promiscuity was calcu-
lated using a 50 nM binding threshold). Promiscuity values calculated based on the two algo-
rithms showed a strong correlation (Spearman’s rho: 0.92, P< 2 × 10−16). (E) The proportion
of epitopes bound by HLA-DRB1 molecules was independent of the exact epitope set used for
the calculations. Specifically, predictions were carried out using epitopes of only extracellular or
only intracellular pathogens, and strong correlation was found between binding promiscuity of
intracellular and extracellular epitopes (Spearman’s rho: 0.99, P< 2 × 10−16). Note that promis-
cuity values are represented in log scale in panels A–C. Red dashed lines indicate linear regres-
sion lines (regression line of log-transformed values on panels A–C). The underlying data for
this figure can be found in S4 Data.
(TIF)
S5 Fig. Increased epitope-binding promiscuity results in the recognition of more patho-
gens. The number of recognized pathogen species (i.e., those with at least one epitope compu-
tationally predicted to be bound by the HLA molecule) is plotted against the computationally
predicted promiscuity of the HLA-DRB1 allele. The two variables are strongly correlated
(Spearman’s rho: 0.99, P< 2 × 10−16). Red curve indicates smooth curve fitted using cubic
smoothing spline method in R (see Methods). Note that promiscuity is represented in log
scale. The underlying data for this figure can be found in S4 Data.
(TIF)
S6 Fig. Phylogeny of DRB1 alleles indicates rapid and frequent changes in promiscuity.
Phylogeny of DRB1 alleles from Yasukochi and colleagues [47], with predicted epitope-bind-
ing promiscuity shown color coded. Alleles were sorted into five equally sized bins according
to their promiscuity values. High promiscuity alleles (dark red) are scattered on the tree, sug-
gesting multiple independent origins. Bootstrap percentage values greater than 80% are shown
on the internal nodes. The underlying data for this figure can be found in S4 Data.
(TIF)
S7 Fig. Amino acid positions in the epitope-binding region of HLA-DRB1 that have a
larger impact on promiscuity are more diverse in human populations. Average nonsynon-
ymous nucleotide diversity of an amino acid site in the epitope-binding region (measured as
πA, see Methods) correlates positively with the site’s promiscuity fragility, measured as the
median predicted promiscuity fold difference caused by a random amino acid change at the
given site (Spearman’s rho = 0.59, P = 0.0075). πA values were calculated for each human popu-
lation using data on allele frequencies (see Methods). Points represent the average πA values of
an amino acid site across all populations. Error bars show standard error. The underlying data
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for this figure can be found in S4 Data.
(TIF)
S8 Fig. Promiscuity fragility and ω values of amino acid sites in the epitope-binding region
of HLA-DRB1 correlate positively. ω or dN/dS value (a common measure of positive selec-
tion) of an amino acid site in the epitope-binding region of HLA-DRB1 (calculated by [48])
correlates positively with the site’s promiscuity fragility, measured as the median predicted
promiscuity fold difference caused by a random amino acid change at the given site (Spear-
man’s rho: 0.72, P = 0.0016, n = 16) (see Methods). The underlying data for this figure can be
found in S4 Data.
(TIF)
S9 Fig. Relationship between intracellular pathogen diversity and HLA class I promiscuity
level. Promiscuity scores were calculated based on standardized (i.e., z-score) allele promiscu-
ity values and were averaged in each population group (see Methods). (A) A significant posi-
tive correlation was found between HLA-A population promiscuity level and intracellular
pathogen diversity (Spearman’s rho: 0.52, P = 0.003), but not between (B) HLA-A population
promiscuity level and extracellular pathogen diversity (Spearman’s rho: 0.03, P = 0.88). There
was a marginally significant positive correlation between (C) HLA-B population promiscuity
level and intracellular pathogen diversity (Spearman’s rho: 0.34, P = 0.03) and (D) no signifi-
cant correlation between extracellular pathogen diversity and HLA-B population promiscuity
level (Spearman’s rho: 0.25, P = 0.12). One might speculate that there might be no selection for
elevated HLA-B promiscuity level due to a dominant balancing selection on this locus (see S1
Text) [7, 8]. Similarly, (E) the promiscuity level of HLA-C molecules showed no significant
correlation with intracellular pathogen diversity (Spearman’s rho: −0.14, P = 0.44). Finally, (F)
HLA-C promiscuity level showed a marginally significant positive correlation with extracellu-
lar pathogen diversity (Spearman’s rho: 0.35, P = 0.04). This is surprising, but this preliminary
result needs to be considered with caution, and studied further in future works. For detailed
explanation of these results, see S1 Text. Population groups were created using the 15th per-
centile genetic distance cutoff (see Methods). For a list of populations assigned to each group,
see S6 Data. For results of multivariate models and obtained upon using alternative distance
cutoff values, see S3 Data. Red curves indicate smooth curves fitted using cubic smoothing
spline method in R (see Methods). The underlying data for this figure can be found in S4 Data.
(TIF)
S1 Table. List of populations and their mean HLA-DRB1 allele promiscuity.
(DOCX)
S2 Table. The relationship between promiscuity and pathogen diversity is independent of
HLA diversity and country size.
(DOCX)
S3 Table. Results of HLA association studies suggest a protective role of high allele promis-
cuity in infectious diseases.
(DOCX)
S1 Text. Pathogen diversity and promiscuity of HLA class I alleles.
(DOCX)
S1 Data. Epitope sequences of pathogenic species used for allele promiscuity prediction.
(XLSX)
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S2 Data. Normalized promiscuity level of HLA-A, -B, -C, and -DRB1 alleles.
(XLSX)
S3 Data. Summary of correlation analyses and multivariate models for HLA-I and HLA-II
loci.
(XLSX)
S4 Data. Underlying data for figures.
(XLSX)
S5 Data. Results of systematic literature search for associations between HLA-DRB1�03
and �12 allelic groups and infectious diseases.
(XLSX)
S6 Data. List of populations included in the analysis of HLA-A, -B, -C loci.
(XLSX)
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